|
|
Zealand Pharma A/S
OTC •
Healthcare •
Biotechnology •
Quote as of 06/23/2026 11:40
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization2,940.3 mln
Float56.67 mln
Earnings Date05/07/2026
P / E
3.22
Deeply undervalued
Relative Strength
20
/ 100
Significantly lagging
Key Fundamentals
EPS13.89
P/E3.22
ROE46.71
RPS19.93
ROIC1,512
ROA42.96
Interest Cover262
EBITDA, mln1,081
EV / EBITDA1.23
EV / EBIT1.24
Revenue, mln1,429
EV / Revenue0.93
Financial Strength
Altman Z-Score19.57
Piotroski F-Score
8
/ 9
Beneish M-Score145
Price to Intrinsic Value1.42
Price to Graham Number0.42
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
2.05% |
80
/ 100
 |
| 1 Month |
-5.32% |
47
/ 100
 |
| 2 Months |
-44.33% |
9
/ 100
 |
| 6 Months |
-23.16% |
28
/ 100
 |
| 1 Year |
-62.72% |
11
/ 100
 |
|
| |